Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPC Study Finds Rx Use Reaches 60% Of Enrollees: Flaw In NIHCM Research?

Executive Summary

A Protocare Sciences analysis of about 1 mil. health plan members finds that the number of patients per 1,000 members taking prescription drugs increased by more than 20% between 1996 and 2000.

You may also be interested in...



DTC Hearing By Senate Commerce Subcmte. Includes Ad Division's Ostrove

FDA Division of Drug Marketing, Advertising & Communications' Nancy Ostrove, PhD, is scheduled to testify at a Senate Commerce/Consumer Affairs Subcommittee hearing on direct-to-consumer advertising May 22.

CBO Remains Skeptical Of Rx Cost Savings In Medicare Estimates

The Congressional Budget Office's baseline numbers for a prescription drug benefit should account for cost-savings achieved by preventative medicines, House Energy & Commerce/Health Subcommittee Chairman Bilirakis (R-Fla.) suggested during a May 16 hearing.

DTC Hearing By Senate Commerce Subcmte. Includes Ad Division's Ostrove

FDA Division of Drug Marketing, Advertising & Communications' Nancy Ostrove, PhD, is scheduled to testify at a Senate Commerce/Consumer Affairs Subcommittee hearing on direct-to-consumer advertising May 22.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel